USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BANYAN BIOMARKERS, INC.
Address:
12085 RESEARCH DR
ALACHUA, FL 32615-
Phone:
N/A
URL:
N/A
EIN:
201449566
DUNS:
168789274
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $880,928.00 4
SBIR Phase II $1,492,266.00 2
STTR Phase I $99,685.00 1

Award List:

Novel Biomarkers for Traumatic Brain Injury

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Injury is the leading cause of mortality among Americans under 45 years of age, and traumatic brain injury (TBI) is responsible for the majority of these deaths. The absence of clinically useful diagnostics has severely impeded effective management and treatment… More

Novel Biomarkers for Stroke Injury

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Stroke is the second leading cause of death worldwide and the primary cause of serious, long-term disability and nursing home admissions. The absence of clinically useful diagnostics has severely impeded effective management and treatment of acute ischemic stroke. Currently available diagnostics are… More

High-Throughput Brain Injury Proteomic Microassay

Award Year / Program / Phase:
2005 / STTR / Phase I
Award Amount:
$99,685.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Monika Oli, Senior Scientist
Research Institution:
UNIV. OF FLORIDA
RI Contact:
Kevin Wang
Abstract:
Traumatic brain injury (TBI) is a leading cause of combat casualty. Previous estimates for 20th century conflicts were that 15 - 25% of all injuries were sustained to the head. However, with the increased incidence of blast injuries that military personnel are suffering in the current conflicts in… More

Biomarker for liver ischemia/reperfusion-induced injury

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,978.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Liver injury induced by hepatic ischemia followed by reperfusion is a major pathogenic cause of liver failure during multiple trauma, thermal injury, hemorrhagic and septic shock, and liver transplantation, which contributes significantly to multiple organ… More

Development of Novel Biomarkers for Traumatic Brain injury

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$754,098.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Each year in the United States at least 1.4 million people seek medical attention for a traumatic brain injury (TBI). Between 75% and 90% of these are mild or moderate injuries. These can inflict profound and persistent impairment of physical, cognitive, and… More

Novel diagnostic and safety biomarkers of liver injury and hepatotoxicity

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$738,168.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Liver damage and failure due to various forms of hepatic injury is a significant source of overall morbidity and mortality in the US and worldwide. Persistent hepatic injury occurs during viral hepatitis, fatty liver di sease (steatohepatitis), drug or alcohol… More

Recombinant hepatic argininosuccinate synthase (rASS) for treatment of sepsis/end

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$580,950.00
Agency:
HHS
Principal Investigator:
Stanislav I. Svetlov – 386-518-6756
Abstract:
DESCRIPTION (provided by applicant): Multiorgan injury and failure due to septic complications result in significant morbidity and mortality, especially in pediatric and elderly patients with severe bacterial infections. Pathogenesis of endotoxic shock/sepsis has not been understood in great detail,… More